COVID-19

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

What lessons were learned from Operation Warp Speed?

How can logistics companies meet the evolving needs of global clients while maintaining resilience over the long-term?

Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.

Could mRNA vaccine be the flu interventions of tomorrow?

We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

What milestones will define the next era in the mRNA story?